Resources Search our curated selection of resources to find out more about the issues, and to help you in your work. Filter by categories All categories Best practices and models Community publications GSIPA2M 2018 Patents: the facts Research Resource Roadmap Trade agreements TRIPS Agreement Video Filter by languages All languages Arabic English French Russian Ukrainian Campaign toolkit – our complete guide Best practices and models Patents: the facts Research Resource Roadmap TRIPS Agreement English Our toolkit will guide you through all the steps to challenge intellectual property barriers, from the life-cycle of a patent,... Access Granted Best practices and models Resource English A budget advocacy toolkit for improving access to quality and affordable medicines through Global Fund grants. Evergreening patents animation Patents: the facts Video English This animation introduces the concept of ‘evergreening’ patents – strategies used by pharmaceutical companies to extend monopolies and keep prices... Analysis of Ukraine’s single-source drug market Research Resource English Report on the analysis of the single-source drugs market in Ukraine. A useful tool for treatment activists, and which can... COVID-19 drugs can be made for $1 a day Resource Video English Our short film (1m 47 secs) shows how all potential drugs for the treatment of COVID-19 can be made affordably.... Minimum costs to manufacture new treatments for COVID-19 Research English ‘Repurposing’ existing drugs to treat COVID-19 is vital to reducing mortality and controlling the pandemic. Researchers from the University of... The problem with patents Patents: the facts Research English This joint policy brief outlines how patents, and their effect on the cost of HIV treatment, threatens to undermine the HIV response in middle-income countries. Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia) Best practices and models English This intellectual property landscapes tool developed in the MENA region can be used to assess the patent landscape in other countries. Дослідження вічнозелених патентів в Україні Research Resource Ukrainian В дослідженні проаналізовано 132 патента, що стосуються найбільш життєво важливих лікарських засобів в Україні на предмет належності до категорії “вічнозелених”.... Evergreening patents in Ukraine Patents: the facts Research English The research analyzes 132 patents for the most important life-saving medicines in Ukraine on whether they can be considered as... The Concept of Compulsory Licensing Resource English The Concept of Implementing a Compulsory Licensing Mechanism in the public Health Sector in Ukraine. A tool for treatment activists... Analysis: ARV procurement, Russia 2019 Community publications Research English ITPC-ru’s 10th year of community-monitoring and analysis in the Russian Federation. EU-Mercosur Bi-regional Association Agreement Community publications Trade agreements English The impact of intellectual property on public procurement of medicines in Argentina. This report analyzes the potential impact on access... TRIPS-plus analysis Ukraine Research Resource English A report on the legal analysis of TRIPS-plus provisions in Ukraine. A look at the legal framework and opportunities for... Access to Hep C treatment among people who inject drugs Community publications Research English A publication produced by Treatment Action Group (TAG) and Médecins du Monde. Activist guide to Hepatitis C diagnostics Community publications Research Resource English Produced by the Treatment Action Group (TAG), the Activist Guide outlines major barriers to accessing testing technologies and services. Why Ukraine needs a Patent Reform for Medicinal Products Best practices and models Resource English Ukraine’s reformed patent law came into effect in August 2020. Read the public health arguments that are relevant and can... Big Pharma Drop the Case! Video Argentina and Brazil launch a campaign to demand that pharmaceutical companies drop their case which threatens access to medicines and... World Trade Organization – TRIPS Agreement Resource TRIPS Agreement The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Global Survey on Access to and Quality of HIV Treatment and Care Research English The 2019 survey focused on barriers to quality HIV care and treatment across 14 low- and middle-income countries covering seven... Анализ закупок АРВ-препаратов в Российской Федерации в 2019 году Community publications Research Russian Коалиция по готовности к лечению Join the Fight – Celebrating HIV Activism Then and Now Community publications Video English This ITPC film looks back at how we started, what’s changed and why community activism is still needed now more... Glossary of Patent Terminology Patents: the facts This document provides a list of patent terminology published by the OECD in 2006. How to Conduct Patent Searches for Medicines Patents: the facts This guide helps to identify whether patents related to a pharmaceutical product exist in the country of interest. This is... Global Summit on IP and Access to Medicines – 2018 Best practices and models Community publications GSIPA2M 2018 Patents: the facts All the presentations from our inaugural GSIPA2M in Marrakech, January 2018. Patentability criteria Patents: the facts Resource English A research synthesis, produced by Knowledge Portalia. MedsPaL – patent information database Patents: the facts Resource English MedsPaL provides information on the patent and licensing status of selected HIV, Hepatitis C, TB and other patented essential medicines... Public Health Related Trips-Plus Provisions in Bilateral Trade Agreements Best practices and models Trade agreements This policy guide highlights the adverse effects of bilateral trade agreements on public health and access to medicines in the... The Roadmap – Special Edition Report on Dolutegravir Best practices and models Roadmap The Initiative for Medicines, Access and Knowledge (I-MAK), has published a special edition ‘Roadmap report’ on dolutegravir. The report provides... UN Secretary General’s High Level Panel on access to medicines report Resource Report: Promoting innovation and access to health technologies. Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia) – Arabic version Best practices and models Arabic Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia) – French version Best practices and models French Отчет о “вечнозеленых” патентах в Украине Patents: the facts Research Russian В исследовании проанализировано 132 патента на наиболее жизненно важные лекарственные средства в Украине на предмет того, относятся ли они к категории... WHO List of Essential Medicines Resource English The World Health Organization (WHO) updates its essential list of medicines every two years. Acuerdo de asociación birregional entre el Mercosur y la Unión Europea Community publications Trade agreements Spanish Impacto del capítulo de propiedad intelectual sobre las compras públicas de medicamentos en la República Argentina. El presente trabajo tiene... At the Edge of a Miracle: The Hepatitis C Virus (HCV) Epidemic in Malaysia Community publications The hepatitis C virus (HCV) has long since been a neglected disease. However, of late, given the development of revolutionary... Compulsory Licensing: Best practices and models Models for State Practices in Developing Countries, Access to Medicine and Compliance with the WHO TRIPS Accord This booklet covers... Дослідження впливу положень ТРІПС+ Patents: the facts Resource Ukrainian Дослідження впливу положень ТРІПС+ на доступність лікарських засобів в Україні Sorry, we can’t find anything that matches.
